Rhoen Klinikum AG (ETR:RHK) Receives €22.17 Consensus Price Target from Analysts

Shares of Rhoen Klinikum AG (ETR:RHK) have received an average rating of “Sell” from the seven ratings firms that are presently covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a sell rating and three have assigned a hold rating to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is €22.17 ($25.78).

Several equities analysts have weighed in on the company. Warburg Research set a €25.50 ($29.65) target price on Rhoen Klinikum and gave the company a “neutral” rating in a research note on Friday, May 3rd. Berenberg Bank set a €26.20 ($30.47) target price on Rhoen Klinikum and gave the company a “neutral” rating in a research note on Tuesday. Independent Research set a €27.00 ($31.40) target price on Rhoen Klinikum and gave the company a “neutral” rating in a research note on Friday, May 10th. Credit Suisse Group set a €16.50 ($19.19) target price on Rhoen Klinikum and gave the company a “sell” rating in a research note on Friday, May 10th. Finally, Kepler Capital Markets set a €19.00 ($22.09) target price on Rhoen Klinikum and gave the company a “sell” rating in a research note on Thursday, April 11th.

ETR:RHK traded down €0.20 ($0.23) during mid-day trading on Monday, hitting €24.55 ($28.55). The company had a trading volume of 18,136 shares, compared to its average volume of 43,281. Rhoen Klinikum has a fifty-two week low of €21.06 ($24.49) and a fifty-two week high of €27.40 ($31.86). The company has a fifty day moving average price of €25.59. The company has a current ratio of 1.76, a quick ratio of 1.61 and a debt-to-equity ratio of 9.74. The stock has a market capitalization of $1.64 billion and a price-to-earnings ratio of 35.07.

About Rhoen Klinikum

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, builds, acquires, and operates primarily acute-care hospitals in Germany. Its hospitals offer treatment services primarily in the areas of cardiovascular, neurology, oncology, pulmonology, orthopedic, accident surgery; rehabilitation and nursing services to the elderly; and thoracic, tumors, and psychosomatic, as well as spinal, column, and joints diseases.

Featured Article: Portfolio Manager

Analyst Recommendations for Rhoen Klinikum (ETR:RHK)

Receive News & Ratings for Rhoen Klinikum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rhoen Klinikum and related companies with MarketBeat.com's FREE daily email newsletter.